Review



cd123 antigen  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Miltenyi Biotec cd123 antigen
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Cd123 Antigen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/CD123+CAR+Detection+Reagent%2C+human%2C+Biotin/pmc07656296-70-10-17
    Average 92 stars, based on 5 article reviews
    cd123 antigen - by Bioz Stars, 2026-09
    92/100 stars

    Images

    1) Product Images from "Dietary Fatty Acids in Postprandial Triglyceride-Rich Lipoproteins Modulate Human Monocyte-Derived Dendritic Cell Maturation and Activation"

    Article Title: Dietary Fatty Acids in Postprandial Triglyceride-Rich Lipoproteins Modulate Human Monocyte-Derived Dendritic Cell Maturation and Activation

    Journal: Nutrients

    doi: 10.3390/nu12103139

    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Figure Legend Snippet: In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).

    Techniques Used: In Vitro, Expressing, Derivative Assay, Activation Assay, Control

    Related Articles

    Flow Cytometry:

    Article Title: Dietary Fatty Acids in Postprandial Triglyceride-Rich Lipoproteins Modulate Human Monocyte-Derived Dendritic Cell Maturation and Activation
    Article Snippet: .. Degree of differentiation of the resulting population was determined for CD123 antigen using anti-human CD123 monoclonal antibody (Miltenyi Biotec) by flow cytometry analysis (more than 95% of cells were positive for CD123) [ , , ]. ..



    Similar Products

    92
    Miltenyi Biotec cd123 antigen
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Cd123 Antigen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/CD123+CAR+Detection+Reagent%2C+human%2C+Biotin/pmc07656296-70-10-17
    Average 92 stars, based on 1 article reviews
    cd123 antigen - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    93
    R&D Systems monomeric recombinant human full length antigen
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Monomeric Recombinant Human Full Length Antigen, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/Recombinant+Human+IL-3R+alpha%2FCD123+Protein/pm39870691-212-3-10
    Average 93 stars, based on 1 article reviews
    monomeric recombinant human full length antigen - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    MacroGenics inc cd123-directed dual antigen re-targeting (dart) agent mgd 006
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Cd123 Directed Dual Antigen Re Targeting (Dart) Agent Mgd 006, supplied by MacroGenics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/mgah22+antibody/us11945863-74-8-7
    Average 90 stars, based on 1 article reviews
    cd123-directed dual antigen re-targeting (dart) agent mgd 006 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cellectis sa allogeneic engineered t cells expressing an anti-cd123 chimeric antigen receptor
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Allogeneic Engineered T Cells Expressing An Anti Cd123 Chimeric Antigen Receptor, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/cd123+car+t/pmc09099711-138-14-0
    Average 90 stars, based on 1 article reviews
    allogeneic engineered t cells expressing an anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Roboz Surgical engineered t-cells expressing anti-cd123 chimeric antigen receptor
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Engineered T Cells Expressing Anti Cd123 Chimeric Antigen Receptor, supplied by Roboz Surgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/engineered+t+cells+expressing+anti+cd123+chimeric+antigen+receptor/pm35287669-425-33-0
    Average 90 stars, based on 1 article reviews
    engineered t-cells expressing anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cellectis sa chimeric antigen receptors (car) directed against the human cd123 antigen
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Chimeric Antigen Receptors (Car) Directed Against The Human Cd123 Antigen, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/cd123+car+t/us10988542-837-31-19
    Average 90 stars, based on 1 article reviews
    chimeric antigen receptors (car) directed against the human cd123 antigen - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Novartis anti-cd123 chimeric antigen receptor engineered t cells
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Anti Cd123 Chimeric Antigen Receptor Engineered T Cells, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/anti+cd123+chimeric+antigen+receptor+engineered+t+cells/pmc07727315__NEJMra2026131_disclosures-156-8-38
    Average 90 stars, based on 1 article reviews
    anti-cd123 chimeric antigen receptor engineered t cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson cd123 antigen
    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) <t>CD123</t> and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).
    Cd123 Antigen, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/anti+cd123/pm29524269-52-69-74
    Average 90 stars, based on 1 article reviews
    cd123 antigen - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cellectis sa allogeneic engineered t-cells with talen system expressing anti-cd123 chimeric antigen receptor
    Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).
    Allogeneic Engineered T Cells With Talen System Expressing Anti Cd123 Chimeric Antigen Receptor, supplied by Cellectis sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd123+antigen/cd123+car+t/pmc06773888-58-5-2
    Average 90 stars, based on 1 article reviews
    allogeneic engineered t-cells with talen system expressing anti-cd123 chimeric antigen receptor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).

    Journal: Nutrients

    Article Title: Dietary Fatty Acids in Postprandial Triglyceride-Rich Lipoproteins Modulate Human Monocyte-Derived Dendritic Cell Maturation and Activation

    doi: 10.3390/nu12103139

    Figure Lengend Snippet: In vitro expression of dendritic cell (DC) gene markers in monocyte-derived DCs (moDCs) after stimulation with TRL-SFAs, TRL-MUFAs and TRL-PUFAs (TRL, triglyceride-rich lipoprotein) at 100 µg of TGs/mL for 6 days and in presence of GM-CSF and interleukin-4 (IL-4). DC maturation markers: ( a ) CD123 and ( b ) CCR7. DC pro-inflammatory activation markers: ( c ) CD80 and ( d ) CD86. DC tolerogenic activation markers: ( e ) PD-L1 and ( f ) PD-L2. Control means non-treated cells in the presence of GM-CSF and IL-4. Values are presented as means ± SD ( n = 6) and those marked with different letters are significantly different ( p < 0.05).

    Article Snippet: Degree of differentiation of the resulting population was determined for CD123 antigen using anti-human CD123 monoclonal antibody (Miltenyi Biotec) by flow cytometry analysis (more than 95% of cells were positive for CD123) [ , , ].

    Techniques: In Vitro, Expressing, Derivative Assay, Activation Assay, Control

    Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).

    Journal: Frontiers in Genetics

    Article Title: Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

    doi: 10.3389/fgene.2019.00868

    Figure Lengend Snippet: Recruited clinical trials based on genome editing technologies (e.g. CRISPR/Cas, ZFN and TALEN).

    Article Snippet: UCART123 , Cellectis S.A. , Allogeneic engineered T-cells with TALEN system expressing anti-CD123 chimeric antigen receptor , AML , NCT03190278.

    Techniques: Clinical Proteomics, CRISPR, Plasmid Preparation, Mutagenesis, Knock-Out, Ex Vivo, Produced, Virus, Control, Expressing, Genetically Modified, Sequencing, Modification, Transfection